Millennium Chief Medical Officer Nancy Simonian: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Exec discusses Millennium’s key pipeline projects, including the T cell integrin antibody MLN0002 for inflammatory bowel disease.
You may also be interested in...
Millennium Shops Atherosclerosis Candidate After Positive Phase II
Biopharma seeks a partner before bringing the CCR2 antagonist into Phase III, firm tells “The Pink Sheet” DAILY.
Millennium Shops Atherosclerosis Candidate After Positive Phase II
Biopharma seeks a partner before bringing the CCR2 antagonist into Phase III, firm tells “The Pink Sheet” DAILY.
Millennium Chief Medical Officer Nancy Simonian: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)
Exec discusses the firm's first year of profitability, the multiple myeloma market and current Velcade strategy following its copromotion deal with J&J.